MXCT vs OMC · rev $38.6M vs rev $17.27B
MaxCyte Inc (MXCT) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
MXCT currently screens at market cap $124.3M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the MXCT and OMC stock pages for the full models.
Not investment advice.